Shire gets FDA approval to produce VPRIV drug substance at Massachusetts facility
The manufacturing plant was previously approved by the European Medicines Agency (EMA) for production of VPRIV drug substance. National Gaucher Foundation CEO and executive director Rhonda Buyers said,